NCT07428616Phase 2Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Study sponsor: Exelixis

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2028-02-29Estimated

Enrollment · participants100Estimated

Source updated2026-09-08Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-05-27 · 1 field changed

Recruitment status

Recorded edit

− Previous value

Not yet recruiting

+ Updated value

Recruiting

Check registry source

Posted 2026-05-18 · 1 field changed

Primary completion date

Recorded edit

− Previous value

2028-02

+ Updated value

2028-02-29

Check registry source